Impedimed

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

MACD Volume

Score

-0.05

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 38 10.5 0.39% 0.54% 8.6% -7.9% -93.3%
SHORT 38 9.7 0.61% 1.35% 10.0% -8.0% 93.5%

Summary

Technical Analysis


Volume Moving Average Convergence/Divergence (VMACD) is an indicator that shows the relationship between two moving averages. It is calculated as a difference between the fast and slow moving averages. The historically popular is the difference between a securities 26-day and 12-day Exponential Moving Averages (EMA).

Calculation: Moving Average Convergence Divergence Volume (VMACD):
1) VMACD Line: (12-day EMA - 26-day EMA);
2) Signal Line: 9-day EMA of VMACD Line;
3) VMACD Histogram: VMACD Line - Signal Line;


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

MACD Volume

Download
Company Close Change(%) Volume Value Signal
PGC Paragon Care 0.29 9.6 1,528,576 -6,235 BEARISH
LNG Liquefied Natural Gas 0.12 9.1 340,710 -388,070 BEARISH
MAQ Macquarie Telecom 28.5 6.1 4,846 -595 BEARISH
TRS Reject Shop 4.54 3.9 174,049 -7,554 BEARISH
FDV Frontier Digital Ventures 1.14 3.6 44,326 -56,271 BEARISH
TLG Talga Gold 0.45 3.5 218,924 -15,949 BEARISH
PNI Pinnacle Investment Management 6.19 3.2 1,394,190 -120,888 BEARISH
LAU Lindsay Australia 0.36 2.9 49,777 -9,886 BEARISH
SNL Supply Network 4.17 2.7 500 -1,047 BEARISH
SVW Seven Holdings 19.7 2.7 632,326 -26,965 BEARISH